Moxifloxacin Methyl Ester

• CAT Number: R056088
• CAS Number: 721970-35-0
• Molecular Formula: C22H26FN3O4
• Molecular Weight: 415.47
• Purity: ≥95%
• Synonyms: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Methyl Ester
• Storage: -20°C
• IUPAC Name: methyl 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylate
• InChI: InChI=1S/C22H26FN3O4/c1-29-21-18-14(20(27)15(22(28)30-2)10-26(18)13-5-6-13)8-16(23)19(21)25-9-12-4-3-7-24-17(12)11-25/h8,10,12-13,17,24H,3-7,9,11H2,1-2H3/t12-,17+/m0/s1
• InChIKey: BUKHHABNOWGLMO-YVEFUNNKSA-N
• SMILES: COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)OC

Moxifloxacin Methyl Ester（Cat No.:R056088）is a synthetic derivative of moxifloxacin, a fourth-generation fluoroquinolone antibiotic. This esterified form enhances lipophilicity, improving membrane permeability and potential prodrug applications. It retains the core quinolone structure responsible for inhibiting bacterial DNA gyrase and topoisomerase IV, critical enzymes for DNA replication. Moxifloxacin methyl ester is primarily used in research to study drug metabolism, pharmacokinetics, and targeted delivery systems. Its modified physicochemical properties make it a useful intermediate in developing novel antibiotic formulations and investigating fluoroquinolone behavior in biological and medicinal chemistry contexts.